The NASH patient-derived organoids exhibited significant up-regulation in their metabolic and pro-inflammatory pathways and showed all typical features of NASH, including reduced albumin secretion, increased apoptosis sensitivity, and lipid accumulation. This evidence concerns the gene ALB and metabolic dysfunction-associated steatohepatitis.